A Phase 1, One Sequence, Cross-over Pharmacokinetic Study to Assess the Interaction Between ASP1707 and Itraconazole, a CYP3A and P-gp Inhibitor in Healthy Female Subjects

Trial Profile

A Phase 1, One Sequence, Cross-over Pharmacokinetic Study to Assess the Interaction Between ASP1707 and Itraconazole, a CYP3A and P-gp Inhibitor in Healthy Female Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Aug 2014

At a glance

  • Drugs ASP 1707 (Primary) ; Itraconazole
  • Indications Endometriosis; Prostate cancer
  • Focus Pharmacokinetics
  • Sponsors Astellas Pharma Europe Ltd
  • Most Recent Events

    • 03 Jul 2014 New trial record
    • 02 Jul 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top